BioMarin Pharmaceuticals
BMRN
BMRN
294 hedge funds and large institutions have $10.1B invested in BioMarin Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 112 increasing their positions, 113 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 280 → 294 (+14)
1% less repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 113
Holders
294
Holding in Top 10
9
Calls
$74.9M
Puts
$41.5M
Top Buyers
| 1 | +$119M | |
| 2 | +$68.6M | |
| 3 | +$38.1M | |
| 4 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
+$34.4M |
| 5 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
+$34.1M |
Top Sellers
| 1 | -$149M | |
| 2 | -$90.3M | |
| 3 | -$77.7M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$62.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$50.4M |